
Ironwood Capital
Overview
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
Torigen Pharmaceuticals | Nov 2022Participated | $13 MSeries A | |
P2 Science | Jan 2020Participated | $12 MSeries C | |
Payveris | Jun 2019Participated | $7 MSeries D | |
IsoPlexis | May 2019Participated | $25 MSeries C | |
IsoPlexis | Sep 2017Participated | $14 MSeries B | |
Precipio Diagnostics | Oct 2013Participated | $2 MSeries B | |
Payveris | Jul 2013Led | $5 MOther Equity | |
LiveClips | Feb 2012Participated | $2 MOther Equity | |
NELS | Jul 2011Led | $7 MOther Equity | |
NovaTract Surgical | Mar 2011Led | $0.15 MSeed | |
Floop | Mar 2011Led | $0.15 MSeed | |
Greenleaf Biofuels | Mar 2011Led | $0.15 MSeed | |
Torigen Pharmaceuticals | Nov 2022Participated | $13 MSeries A | |
P2 Science | Jan 2020Participated | $12 MSeries C | |
Payveris | Jun 2019Participated | $7 MSeries D | |
IsoPlexis | May 2019Participated | $25 MSeries C | |
IsoPlexis | Sep 2017Participated | $14 MSeries B | |
Precipio Diagnostics | Oct 2013Participated | $2 MSeries B | |
Payveris | Jul 2013Led | $5 MOther Equity | |
LiveClips | Feb 2012Participated | $2 MOther Equity | |
NELS | Jul 2011Led | $7 MOther Equity | |
NovaTract Surgical | Mar 2011Led | $0.15 MSeed | |
Floop | Mar 2011Led | $0.15 MSeed | |
Greenleaf Biofuels | Mar 2011Led | $0.15 MSeed |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Seed | 3 | 0 |
| Series A | 0 | 1 |
| Series B | 0 | 2 |
| Series C+ | 0 | 4 |
| Other Equity | 2 | 1 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Oct '09 | 1 |
| Nov '09 | 0 |
| Dec '09 | 0 |
| Jan '10 | 0 |
| Feb '10 | 0 |
| Mar '10 | 0 |
| Apr '10 | 0 |
| May '10 | 0 |
| Jun '10 | 0 |
| Jul '10 | 0 |
| Aug '10 | 0 |
| Sep '10 | 0 |
| Oct '10 | 0 |
| Nov '10 | 0 |
| Dec '10 | 0 |
| Jan '11 | 0 |
| Feb '11 | 0 |
| Mar '11 | 3 |
| Apr '11 | 0 |
| May '11 | 0 |
| Jun '11 | 0 |
| Jul '11 | 1 |
| Aug '11 | 0 |
| Sep '11 | 0 |
| Oct '11 | 0 |
| Nov '11 | 0 |
| Dec '11 | 0 |
| Jan '12 | 0 |
| Feb '12 | 1 |
| Mar '12 | 0 |
| Apr '12 | 0 |
| May '12 | 0 |
| Jun '12 | 0 |
| Jul '12 | 0 |
| Aug '12 | 0 |
| Sep '12 | 0 |
| Oct '12 | 0 |
| Nov '12 | 0 |
| Dec '12 | 0 |
| Jan '13 | 0 |
| Feb '13 | 0 |
| Mar '13 | 0 |
| Apr '13 | 0 |
| May '13 | 0 |
| Jun '13 | 0 |
| Jul '13 | 1 |
| Aug '13 | 0 |
| Sep '13 | 0 |
| Oct '13 | 1 |
| Nov '13 | 0 |
| Dec '13 | 0 |
| Jan '14 | 0 |
| Feb '14 | 0 |
| Mar '14 | 0 |
| Apr '14 | 0 |
| May '14 | 0 |
| Jun '14 | 0 |
| Jul '14 | 0 |
| Aug '14 | 0 |
| Sep '14 | 0 |
| Oct '14 | 0 |
| Nov '14 | 0 |
| Dec '14 | 0 |
| Jan '15 | 0 |
| Feb '15 | 0 |
| Mar '15 | 0 |
| Apr '15 | 0 |
| May '15 | 0 |
| Jun '15 | 0 |
| Jul '15 | 0 |
| Aug '15 | 0 |
| Sep '15 | 0 |
| Oct '15 | 0 |
| Nov '15 | 0 |
| Dec '15 | 0 |
| Jan '16 | 0 |
| Feb '16 | 0 |
| Mar '16 | 0 |
| Apr '16 | 0 |
| May '16 | 0 |
| Jun '16 | 0 |
| Jul '16 | 0 |
| Aug '16 | 0 |
| Sep '16 | 0 |
| Oct '16 | 0 |
| Nov '16 | 0 |
| Dec '16 | 0 |
| Jan '17 | 0 |
| Feb '17 | 0 |
| Mar '17 | 0 |
| Apr '17 | 0 |
| May '17 | 0 |
| Jun '17 | 0 |
| Jul '17 | 0 |
| Aug '17 | 0 |
| Sep '17 | 1 |
| Oct '17 | 0 |
| Nov '17 | 0 |
| Dec '17 | 0 |
| Jan '18 | 0 |
| Feb '18 | 0 |
| Mar '18 | 0 |
| Apr '18 | 0 |
| May '18 | 0 |
| Jun '18 | 0 |
| Jul '18 | 0 |
| Aug '18 | 0 |
| Sep '18 | 0 |
| Oct '18 | 0 |
| Nov '18 | 0 |
| Dec '18 | 0 |
| Jan '19 | 0 |
| Feb '19 | 0 |
| Mar '19 | 0 |
| Apr '19 | 0 |
| May '19 | 1 |
| Jun '19 | 1 |
| Jul '19 | 0 |
| Aug '19 | 0 |
| Sep '19 | 0 |
| Oct '19 | 0 |
| Nov '19 | 0 |
| Dec '19 | 0 |
| Jan '20 | 1 |
| Feb '20 | 0 |
| Mar '20 | 0 |
| Apr '20 | 0 |
| May '20 | 0 |
| Jun '20 | 0 |
| Jul '20 | 0 |
| Aug '20 | 0 |
| Sep '20 | 0 |
| Oct '20 | 0 |
| Nov '20 | 0 |
| Dec '20 | 0 |
| Jan '21 | 0 |
| Feb '21 | 0 |
| Mar '21 | 0 |
| Apr '21 | 0 |
| May '21 | 0 |
| Jun '21 | 0 |
| Jul '21 | 0 |
| Aug '21 | 0 |
| Sep '21 | 0 |
| Oct '21 | 0 |
| Nov '21 | 0 |
| Dec '21 | 0 |
| Jan '22 | 0 |
| Feb '22 | 0 |
| Mar '22 | 0 |
| Apr '22 | 0 |
| May '22 | 0 |
| Jun '22 | 0 |
| Jul '22 | 0 |
| Aug '22 | 0 |
| Sep '22 | 0 |
| Oct '22 | 0 |
| Nov '22 | 1 |
| Dec '22 | 0 |
| Jan '23 | 0 |
| Feb '23 | 0 |
| Mar '23 | 0 |
| Apr '23 | 0 |
| May '23 | 0 |
| Jun '23 | 0 |
| Jul '23 | 0 |
| Aug '23 | 0 |
| Sep '23 | 0 |
| Oct '23 | 0 |
| Nov '23 | 0 |
| Dec '23 | 0 |
| Jan '24 | 0 |
| Feb '24 | 0 |
| Mar '24 | 0 |
| Apr '24 | 0 |
| May '24 | 0 |
| Jun '24 | 0 |
| Jul '24 | 0 |
| Aug '24 | 0 |
| Sep '24 | 0 |
| Oct '24 | 0 |
| Nov '24 | 0 |
| Dec '24 | 0 |
| Jan '25 | 0 |
| Feb '25 | 0 |
| Mar '25 | 0 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 0 |
| Oct '25 | 0 |
| Nov '25 | 0 |
| Dec '25 | 0 |
| Jan '26 | 0 |
| Feb '26 | 0 |
| Mar '26 | 0 |
| Apr '26 | 0 |
| May '26 | 0 |
| Jun '26 | 0 |
| Jul '26 | 0 |
| Aug '26 | 0 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 6 |
| Enterprise Software | 3 |
| Fintech | 2 |
| Manufacturing | 2 |
| Clean Energy & Sustainability | 2 |
| Social & Community Platforms | 1 |
| Consumer & Lifestyle | 1 |
| Networks, Cloud & Communication | 1 |
| Marketing & Advertising | 1 |
| Media & Entertainment | 1 |
| E-Commerce & Retail | 1 |
| Space & Frontier Tech | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 5 |
| $5M-$10M | 3 |
| $10M-$25M | 3 |
| $25M-$50M | 2 |
| $50M-$100M | 0 |
| $100M-$250M | 0 |
| $250M-$500M | 0 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 1 of 1 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 13 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Connecticut Innovations | 8 |
| Advantage Capital | 6 |
| Spring Mountain Capital | 2 |
| BASF Venture Capital | 1 |
| Bessemer Venture Partners | 1 |
| Black Dragon Capital | 1 |
| Cardinal Venture Capital | 1 |
| Chanel | 1 |
| Coral Group | 1 |
| Elm Street Ventures | 1 |
| Emerald Development Managers | 1 |
| Enhanced Capital | 1 |
| Focus Ventures | 1 |
| Gaingels | 1 |
| HG Ventures | 1 |
| Kema Fund | 1 |
| Kuzari Group | 1 |
| Mosaik Partners | 1 |
| North Sound Capital | 1 |
| North Sound Ventures | 1 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 5 | 38% |
| Participating | 8 | 62% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 0 | 0% |
| Co-led | 5 | 100% |
Team
Founding Partner, President and Chief Investment Officer
Partner
Chief Compliance Officer and VP of Investment Operation
Partner and Chief Operating Officer
Managing Director
Managing Director
Partner and Chairman
Managing Director